The MRFF 2026 BioMedTech Incubator supports suitable organisations in identifying, selecting, and supporting Australian SMEs undertaking early-stage medical research and medical innovation projects that possess commercial potential.
This opportunity is part of the Medical Research Future Fund under the Medical Research Commercialisation Initiative. The intended outcome of the research funded is to improve the health and wellbeing of Australians by increasing the number of SMEs developing novel biomarkers, diagnostics, therapeutics, assistive devices, and/or digital technologies. These innovations must have progressed through the early stages of research and development to a point where they are 'de-risked' and attractive to private investment for commercialisation. Applicants may propose to support development of innovations within their area(s) of strength; applicants are not required to propose a program covering the breadth of the biomedtech sector.
Applicants must possess an Australian business number (ABN) and be incorporated in Australia. Furthermore, applicants must, in accordance with s24 of the MRFF Act 2015, be one of the following entities:
Exclusions apply to the following entities:
Applicants may partner with one or more other organisations that also meet the eligibility criteria. The group must designate a lead organisation, which is responsible for completing the application form, signing the grant agreement, receiving grant payments, and ensuring the group adheres to all rules and reporting requirements outlined in the grant agreement.
Total Amount Available (AUD): $132,000,000.00
Estimated Grant Value (AUD): From $0.00 to $33,000,000.00
To apply, submissions must be made via the following web address: www.business.gov.au/BMTI-2026.
Close Date & Time: 22-Jul-2026 5:00 pm (ACT Local Time)
Publish Date: 26-Feb-2026
For further assistance, please use the following details:
Analyze this opportunity instantly
Ensure you have all required documents before starting your application.
Submission Deadline
Jul 22, 2026
Collaboration
Industry–academia
Questions about this grant?
Log in to create free customized alerts based on your prefernces